Calendar items from The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute The 2010 Lung Cancer Conference sponsored by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute will be held from 8 a.m. to 5 p.m. on Nov. 3 at the Biomedical Research Tower, 460 W. 12th Ave., Columbus, Ohio; course directors are Dr. Greg Otterson and Dr. Patrick Ross and a maximum of 7 AMA PRA Category 1 credits. For more information, visit http://cancer.osu.edu/go/Lung2010. The 2010 Ernest L. Mazzaferri Thyroid Cancer Conference sponsored by The Ohio State University Medical Center in cooperation with the Department of Internal Medicine and The Ohio State University Comprehensive Cancer Center will be held from 8a.m. to 5p.m. on Nov. 19 at the Biomedical Research Tower, 460 W. 12th Ave., Columbus, Ohio; maximum of 8.25 AMA PRA Category 1 credits.  The 2010 Gastrointestinal Cancers Conference sponsored by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and The Ohio State University Center for Continuing Medical Education will be held Oct. 8 at the Hyatt on Capital Square, 75 E. State St., Columbus, Ohio; maximum of 6.75 Category 1 credits of the Physician’s Recognition Award of the American Medical Association. For more information, visit http://cancer.osu.edu/go/GICancers2010. The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (cancer.osu.edu) is one of only 40 Comprehensive Cancer Centers in the United States designated by the National Cancer Institute. Ranked by U.S. News & World Report among the top cancer hospitals in the nation, The James is the 180-bed adult patient-care component of the cancer program at The Ohio State University. The OSUCCC-James is one of only seven funded programs in the country approved by the NCI to conduct both Phase I and Phase II clinical trials. # # # Jennifer Mutchler Medical Center Public Affairs and Media Relations 614-293-3737 Jennifer.Mutchler@osumc.edu